2. Who is GlobalMed Tech, (GMT)
• GMT is a Bio Medical Technology Company.
• GMT has developed a treatment modality which effectively
inactivates the HIV virus.
• GMT has Government approval to conduct Controlled Clinical
Trials on 100 subjects in South America.
• GMT has patented it’s process and products worldwide.
• GMT Manufactures 5 Main Components:
• PCI-1 Hemoirradiator
• The GMT - Electronic Master Control Card
• GMT Proprietary Software
• Patient Intelli - Flash drive Software
• The GMT – Cuvette, ( Irradiation Chamber )
3. PCI
THE PROCESS OF HEMOIRRADIATION.
• PCI IS THE PROCESS OF EXPOSING A CERTAIN
QUANTITY OF BLOOD TO ULTRAVIOLET
IRRADIATION VIA A STERILE CLOSED
CIRCUIT, CALLED A CUVETTE OR
IRRADIATION CHAMBER.
• THE BLOOD NEVER COMES IN CONTACT
WITH THE AMBIENT ENVIRONMENT.
4. FUNCTION
• AS IN ANY FORM OF THERAPY, THE SUCCESS
OF HEMOIRRADIATION IS DEPENDANT ON
THE DOSAGE ADMINISTERED.
• AND
• THE CURATIVE PROPERTIES IN VIVO IS
DERIVED FROM THE ACTIVATION AND
STIMULATORY EFFECT UPON CELLS AND
MOLECULES WHICH COMPOSE HUMAN
BLOOD.
5. NIELS FINSEN
• FATHER OF
PHOTOTHERAPY:
• Won Nobel Prize in Physiology &
Medicine in 1903 “In recognition of his
contribution to the treatment of diseases,
especially Lupus Vulgaris, with
concentrated light radiation, whereby he
has opened a new avenue for medical
science“
• Dr. Finsen’s contribution to medicine is
unparallel. He treated 300 patients with
Lupus Vulgaris and demonstrated, 100%
success rates. Today, we have nothing in
our arsenal of medications that can
produce such results.
6. Lester Edblom, medical
student and Dr. Emmet
Knott scientist, developed
the first Hemoirradiator
vacuum extraction system
and Cuvette. The first
Patent was issued in the
US for a UV-Irradiator.
September 11, 1928.
Thousands of people
were treated between the
1930’s up to 1969 with a
98% success rate..
15. THERAKOS
JOHNSON & JOHNSON
Ultraviolet A
Irradiator
Irradiator developed by Dr.
Elderson and utilized in
clinical trials on AIDS
Related ARC patients at
Columbia University in 1990.
Four subjects were registered
as SERO Negative after 5 to
19 Sessions.
24. Hep-Loc IV Catheter Placement.,
Used to extract and re infuse
patients blood during treatment.
Placement
of
GMT-Hep-Loc
25. Blood Extraction
Process
• Patient sits comfortably and may
watch television, read or listen to
music during their sessions.
•Up to 300ml of blood is extracted.
• Time of Treatment:
Extraction 7-10 min.
Irradiation 5 min
Re Infusion 7-10 min
• Total Time : 19-25 min
27. Irradiation Process.
The blood is propelled by the Peristaltic Pump
via the Irradiation Chamber (Cuvette) where the
blood is irradiated with the precise amount of UV
Dosage. After irradiation the blood continues to
the secondary Blood Bag and from there is
returned via a Blood Administration Kit with a
70um Filter.
34. Virus Destruction
2 Hours 4 Hours 6 Hours
The destruction of a Virus is achieved by
Fragmentation which Inactivates the Virus.
35. Destruction of Fungus
The Destruction of Fungus is achieved by the
Photo-Oxidation effect on their Membranes
which prohibits Biosynthesis.
Before 24 Hours 48 Hours
37. PROTOCOLO ISUV-001-04
STUDY DECREASE PROGRESSION
VIRAL LOAD VIRAL LOAD
• ROCHE 116A (8 WEEKS) 52% 48%
• ROCHE 116A (16 WEEKS) 46% 54%
• ROCHE 116B/117 (8 WEEKS) 55% 45%
• ROCHE 116B/117 (16 WEEKS) 55% 45%
• GMT-PCI 2004-001 (4 WEEKS) 58% 42%
• GMT-PCI 2004-001 (8 WEEKS) 76% 24%
• GMT-PCI 2004-001 (12 WEEKS) 84% 16%
GMT PCI REGIMENT
COMPARED TO A DOUBLE BRANCH STUDY PERFORMED BY
ROCHE , UTILIZING RETROVIRAL REGIMENT OF
ZDV, AND ddl.
38. BEFORE AND AFTER PHOTOS.
AFTER 90 DAYS OF TREATMENT, 100%
OF OPPORTUNISTIC INFECTIONS HAD
SUBSIDED.
GMT believes it can reduce the cost to keep
one HIV/AIDS patient alive by 90% a year.
Savings to Medicare and Medicaid would be in the Billions.
Current Across the Board yearly cost in US to keep 1 million
HIV/AIDS patients alive = 20 Billion
Estimated cost with GMT Protocol 1 million patients
1.5 to 2 Billion
39. PRE TREATMENTPRE TREATMENT AFTER 2AFTER 2
TREATMENTS.TREATMENTS.
WEEK 2WEEK 2
AFTER 4AFTER 4
TREATMENTS.TREATMENTS.
WEEK 4WEEK 4
